Overview of the Health Innovation Award 2026: Promoting Sustainable Solutions in Healthcare

By João L. Carapinha

May 27, 2026

Health Innovation Award

The Health Innovation Award continues its mission in 2026 by spotlighting data-driven projects that advance sustainability across Portugal’s health sector. Launched by Faculdade de Medicina da Universidade de Lisboa, Sanofi, and NTT DATA Portugal, it invites submissions through its dedicated platform.

Core Categories Highlight Impact Areas

  • Sustainability Social
  • Sustainability Económica
  • Sustainability Ambiental
  • Sustainability na Transformação Digital

These four tracks, centered on the theme “Dados que transformam a saúde,” reward measurable contributions from individuals, institutions, and students alike.

Past Winners Showcase Proven Results

The Health Innovation Award has already recognized standout initiatives such as iSIGHT for equitable eye care and EcoScan for energy-efficient imaging. AI-powered solutions like ConversAI further demonstrate scalable clinical improvements.

Evaluation Ensures Rigorous Selection

A seven-member jury scores proposals on organization, sustainability alignment, and replication potential across five clear phases. Conflict-of-interest rules and external consultation maintain transparency throughout the process.

Subscribe to Syenza Newsletter
Reference url

Recent Posts

Biotechnology Act Europe
Biotechnology Act Europe Driving Innovation and Investment in Life Sciences

By João L. Carapinha

June 18, 2026

The Biotechnology Act Europe offers a once-in-a-generation chance to turn the continent’s world-class life sciences research into scalable commercial successes that remain in Europe rather than migrating elsewhere. By tackling regulatory fragmentation and sharpening investment signals, the legisl...
FDA Importation Program Analysis
FDA Importation Program Analysis on Colorado’s Prescription Drug Initiative

By João L. Carapinha

June 18, 2026

This FDA Importation Program Analysis confirms that Colorado has secured a two-year authorization to import eligible prescription drugs under its Section 804 Importation Program (SIP), demonstrating that significant cost savings for American consumers are achievable without compromising safety or...
real-world evidence Portugal
Enhancing Health Technology Assessment Through Real-World Evidence in Portugal

By João L. Carapinha

June 17, 2026

Real-world evidence Portugal has moved from supplementary tool to statutory requirement under Decree-Law 118/2026, which compels national health systems to share interoperable data so that promised outcomes can be verified after medicines and devices reach patients. The legislation converts one-t...